Research Grants
The ATA® is committed to supporting research into better ways to diagnose and treat thyroid disease. The generosity of members, patients, industry, and donors in the workplace has enabled the ATA® to award 99 thyroid research grants totaling over $2.6 million since the inception of the Research Fund. In addition, the ATA® rigorously manages the selection of research projects and distribution of over $2.7 million generously donated to the ATA® specifically for research grants from ThyCa: Thyroid Cancer Survivors’ Association, Inc., Bite Me Cancer and Thyroid Head and Neck Cancer Foundation.
The Thyroid Cancer Survivors’ Association, Inc. (ThyCa), has provided funding since 2003 in support of 72.5 special research grants totaling $2,039,375 focused on thyroid cancer and medullary thyroid cancer. In 2018 ThyCa is supporting half of a new medullary thyroid cancer grant with Bite Me Cancer, two new thyroid cancer research grants, and three renewing grants. ThyCa is a member of the ATA Alliance for Patient Education. Find out more at www.thyca.org.
Bite Me Cancer (BMC) is our newest grant funder, supporting 8.5 thyroid cancer grants since 2014 for a total of $244,375. BMC will be supporting a half of a new medullary thyroid cancer grant in 2018 with ThyCa and one renewing thyroid cancer grant. BMC is a member of the ATA Alliance for Patient Education. Find out more at www.bitemecancer.org.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.